RxDoctor Payments Data

Wyman McGuirt, MD

Otolaryngology · Pinehurst, NCNPI 1053335919

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,873 of the $6,112 with a category attached, or 63.4%. 22 manufacturers reported payments, led by Intersect ENT, Inc. at 43.8% of the total. Reporting peaked in 2019 at $2,994 and has fallen 80.7% since, to $577 in 2025. Among otolaryngology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,112in general payments, 2019–2025

Across 127 payments — averaging $48.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intersect ENT, Inc.$3K
  • GSK$667
  • Sanofi$506
  • Acclarent, Inc$429
  • Cochlear Americas$379
  • Medtronic$331
  • plus $1K from 16 others

What the payments were for

  • Travel & lodging$2,23937%
  • Food & beverage$3,87363%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,112 in reported general payments places this provider in the 90th percentile of 362 otolaryngology providers in North Carolina.

See all otolaryngology providers in North Carolina

Medicare billing

Part B allowed, 2024
$287,456
Medicare patients
792
Services billed
3,093

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Varenicline Tartrate19$4,379
Mometasone Furoate40$4,316
Ipratropium Bromide124$3,898
Fluticasone Propionate226$2,893
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth17$2,000
Fluocinolone Acetonide Oil38$1,484
Famotidine92$815
Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort14$676
Azelastine Hcl27$618
Levocetirizine Dihydrochloride67$614
Doxycycline Monohydrate49$473
Levothyroxine Sodium65$432
Omeprazole48$357
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav20$209
Cephalexin47$206

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Pinehurst

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →